Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-021132

President and CEO sold 5,356 shares at an average $0.64 ($3,454)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lucchino David L. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-19 Sale : show line 1 in the form 10b5-1 −2,646 $0.65 $1,720 697,193 D
2023-07-20 Sale : show line 2 in the form 10b5-1 −2,710 $0.64 $1,734 694,483 D
Open-market sales · 5,356 sh · avg $0.64 · $3,454
Loading xslF345X05/form4.xml…